Calatrava, Marcela P.

HRN: 21-56-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2022
CO-AMOXICLAV 625MG (TAB)
08/08/2022
08/14/2022
PO
625mg
Q8hrs
Gangrenous Foot
Waiting Final Action 
08/08/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/08/2022
08/15/2022
IVT
300mg
Q6hrs
Gangrenous Foot
Waiting Final Action 
08/08/2022
CEFTRIAXONE 1G (VIAL)
08/08/2022
08/14/2022
IV
2gm
Q24
Gangrenous 2nd Digit Left Foot; (shift From Co-amoxiclav)
Waiting Final Action 
08/16/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/16/2022
08/23/2022
IVT
600mg
Q6hrs
Gangrenous Left Foot
Waiting Final Action 
08/17/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/17/2022
08/24/2022
TOPICAL
1%
OD
Gangrenous 2nd Digit L Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: